Method of using soluble human interleukin-1 receptors to suppress inflammation
US5488032A · kind A · utility
65Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1992 |
| Grant date | Jan 30, 1996 |
| Priority date | — |
| Expiry date | Jun 17, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/141
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Methods of using shulL-1Rs to suppress IL-1 mediated inflammation in a mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.